Another multi-biomarker approach presented a 3-biomarker model (IL-17, IL-1ra and VEGF) distinguishing healthy implant PICF from PID subjects with high validity (AUC: 0.90) [35]. Here, IL17A is linked to pelvic inflammatory disease.